NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024

A Tender Notice
by NHS ENGLAND

Source
Contracts Finder
Type
Framework (Products)
Duration
4 year
Value
£2B
Sector
HEALTH
Published
03 Nov 2023
Delivery
01 May 2024 to 30 Apr 2028
Deadline
08 Dec 2023 13:00

Concepts

Location

Geochart for 1 buyers and 0 suppliers

1 buyer

Description

Project Title: NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024 Offer reference number: CM/PHR/22/5682 CM/PHR/22/5682/01 - NHS Framework Agreement for Branded Medicines - National Tender - Lot 1. Period of framework: 1 May 2024 to 30 April 2028. CM/PHR/22/5682/02 - NHS Framework Agreement for Branded Medicines - National Tender - Lot 2. Period of framework: 1 May 2024 to 30 April 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Contract is suitable for SMEs.

Other Information

To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome. Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at: Phone: 0800 9956035 E-mail: support-health@atamis.co.uk Document No. 07b - Quality Assurance Policy to support the National Contract Procurement of Licensed Medicines v6 (Issued October 2023) Document No. 07b - Quality Assurance Policy to support the National Contract Procurement of Licensed Medicines v6 (Issued October 2023).pdf Document No. 09 - Tender design and instructions on completing the offer schedule Document No. 09 - Tender design and instructions on completing the offer schedule.doc Document No. 10 - Pharmacy Purchasing Points List - CM-PHR-22-5682 Document No. 10 - Pharmacy Purchasing Points List - CM-PHR-22-5682.xls Document No. 05 - Selectt offer schedule instructions - CM-PHR-22-5682 Document No. 05 - Selectt offer schedule instructions - CM-PHR-22-5682.docx Document No. 05a(i) Selectt Offer Schedule - CM_PHR_22_5682_01 Document No. 05a(i) Selectt Offer Schedule - CM_PHR_22_5682_01.xml Document No. 05a(ii) Selectt Offer Schedule - CM_PHR_22_5682_02 Document No. 05a(ii) Selectt Offer Schedule - CM_PHR_22_5682_02.xml Document No. 01 - Invitation to offer covering letter - CM-PHR-22-5682 Document No. 01 - Invitation to offer covering letter - CM-PHR-22-5682.docx Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements Document No. 04b - Assessment Criteria, Stability Protocol and Additional Specification Requirements.pdf Document No. 04a - Quality Assurance Process Document No. 04a - Quality Assurance Process.pdf Document No. 08 - Confidential information schedule - CM-PHR-22-5682 Document No. 08 - Confidential information schedule - CM-PHR-22-5682.xls Document No. 03 - Framework Agreement and Terms and Conditions Document No. 03 - Framework Agreement and Terms and Conditions.pdf Document No. 02 - Terms of offer Document No. 02 - Terms of offer.docx Document No. 05c - Volume discounts or Additional Products Offer Schedule - CM-PHR-22-5682 Document No. 05c - Volume discounts or Additional Products Offer Schedule - CM-PHR-22-5682.xls Document No. 05d - Supplementary usage data for Diltiazem MR-Fentanyl patch-Morphine MR-Nifedipine MR and Ropinirole MR v4 Document No. 05d - Supplementary usage data for Diltiazem MR-Fentanyl patch-Morphine MR-Nifedipine MR and Ropinirole MR v4.xlsx Document No. 06 - Form of offer - CM-PHR-22-5682 Document No. 06 - Form of offer - CM-PHR-22-5682.doc Document No. 07a - Quality control technical sheet Document No. 07a - Quality control technical sheet.pdf Document No. 05b(ii) - Tender Product Listing and Usage CM-PHR-22-5682 Document No. 05b(ii) - Tender Product Listing and Usage CM-PHR-22-5682.xlsx Document No. 05b(i) - Tender Product Listing and Usage CM-PHR-22-5682 Document No. 05b(i) - Tender Product Listing and Usage CM-PHR-22-5682.xlsx

Reference

Domains